No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

MedReps Reveals Medical Sales Professionals’ Top Choice Employers

Editor: What To Know

  • It is part of our Core Values and is the heart and soul of our company, and it's a prime reason our team is able to deliver on our commitments to healthcare professionals facing enormous challenges,” said Teleflex Corporate Vice President and Chief Human Resources Officer Cam Hicks, voted number one for large companies.
  • “Given the continued challenges medical sales reps faced in 2021, valuing leadership and culture in their place of work isn't a surprise – and it's important to recognize employers, like these companies on this list, that are doing much to support their employees,” said CEO Josh Goodwin.
  • The 2022 Best Places to Work in Medical Sales report polled over 2,300 MedReps community professionals to identify which medical sales companies are currently the most sought-after in the industry.

A new survey by MedReps, a career site for medical sales representatives, revealed Teleflex, CONMED and Medtronic as the top three best large employers to work for. Avion and Acella Pharmaceuticals, 23andMe and Precision Medical were voted best small employers.

The 2022 Best Places to Work in Medical Sales report polled over 2,300 MedReps community professionals to identify which medical sales companies are currently the most sought-after in the industry.

The survey results also identified the qualities and values most important to medical sales reps today. Pay and leadership were on par for being the most important consideration in an employer, followed very closely by culture.

“Given the continued challenges medical sales reps faced in 2021, valuing leadership and culture in their place of work isn’t a surprise – and it’s important to recognize employers, like these companies on this list, that are doing much to support their employees,” said CEO Josh Goodwin. “We’re thrilled to highlight deserving employers to our community of medical sales professionals.”

“While COVID has certainly accelerated the creation of employee programs, Teleflex has always been committed to putting people at the center of all we do. It is part of our Core Values and is the heart and soul of our company, and it’s a prime reason our team is able to deliver on our commitments to healthcare professionals facing enormous challenges,” said Teleflex Corporate Vice President and Chief Human Resources Officer Cam Hicks, voted number one for large companies.

Speaking for Avion and Acella Pharmaceuticals, the top-voted small company, “Our leaders work and live through the philosophy of treating others the way they want to be treated,” said Avion Chief Executive Officer, Harold “Art” Deas.

To view the full list of top 10 large and top 10 small employers, click here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy